Related research shows blood or urine sample can be used
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) in San Francisco, Nov. 14-16. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
“Our novel HCV antigen test system has significantly improved sensitivity and specificity over current tests. Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection,” said Hu, professor of gastroenterology and hepatology at UC Irvine School of Medicine. “Finding a more convenient, easy-to-use and cost-effective screening alternative is imperative, because HCV is significantly under-screened and under-diagnosed.”
Although the current HCV screening test is specific and sensitive, it cannot distinguish active infection from a previous infection. A blood sample is required, and two steps are required. First, virus-specific antibodies must be detected in the blood. Then, the sensitive HCV RNA PCR test must be administered to confirm whether or not the infection is active. Hu said many developing countries are not equipped to administer the two-step test, especially the HCV RNA PCR test. In the U.S., its cost is above $200. The novel HCV antigen test system developed by Hu’s UC Irvine lab could significantly reduce the cost, human resources and time required for the test results.
“The ability to detect infection using urine rather than blood avoids needle stick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale,” Hu said.
According to the Centers for Disease Control and Prevention, approximately 150 million people worldwide and 3.2 million people in the U.S. are infected with HCV. Effective screening and fast diagnosis are critical for treatment and controlling transmission.
“Those who are HCV infected can now be cured, before a further liver injury and complications develop, but only if they are diagnosed” Hu said.
The Latest on: Hepatitis C
via Google News
The Latest on: Hepatitis C
- You’re Diagnosed with Hepatitis C, Now What? on March 4, 2019 at 11:29 am
You’ve been diagnosed with hepatitis C, now what? Don’t panic. I can offer you some reassurance. I was in the same position as you are 10 years ago, and I have insider information that may calm your f... […]
- Penn researchers find transplant potential in hepatitis C-positive hearts on March 4, 2019 at 2:06 am
A team of Penn surgeons has successfully transplanted hepatitis C-infected hearts into uninfected patients and then cured them of the virus, according to a new study published by the American Journal ... […]
- Slum dwellers to get free testing, treatment for hepatitis C and TB on March 2, 2019 at 4:00 pm
Slum dwellers of Islamabad will now get screening, testing and treatment for hepatitis C and other infectious diseases like tuberculosis (TB). Federal Minister of National Health Services Aamer Mehmoo... […]
- Despite obstacles, hepatitis C program connects patients to treatment on March 1, 2019 at 3:53 pm
Despite obstacles, hepatitis C program connects patients to treatment A pilot program to connect people with hepatitis C treatment is encountering barriers to get folks treated. Check out this story o... […]
- Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor on March 1, 2019 at 1:54 pm
Chronic hepatitis C virus (HCV) infection is a leading cause of liver-related morbidity and mortality worldwide. In addition, chronic HCV infection is considered a systemic infection with many extrahe... […]
- Companies, states interested in Louisiana hepatitis C plan on March 1, 2019 at 1:46 pm
BATON ROUGE, La. (AP) — Three drug companies are interested in Louisiana's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners, a trea... […]
- 3 companies vying to become state partner on Hepatitis C treatment for Medicaid patients, prisoners on March 1, 2019 at 1:00 pm
Louisiana is one step closer to implementing a new method of obtaining normally pricey Hepatitis C drugs — a move that health officials hope will drive down costs and ultimately help the state eradica... […]
- Drug companies interested in Louisiana hepatitis C drug plan on March 1, 2019 at 12:22 pm
BATON ROUGE, La. (AP) — Three drug companies are interested in Louisiana's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners. Health ... […]
- Global Hepatitis C Therapeutics Market to Witness Huge Growth by 2023 on March 1, 2019 at 1:22 am
ResearchMoz include new market research report "Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Cli... […]
- HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid on February 28, 2019 at 9:37 am
Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending o... […]
via Bing News